Fresenius Kabi Recalls Fluorouracil Injection Due to Glass Particulates
Fresenius Kabi USA, LLC is recalling 14,016 vials of Fluorouracil Injection due to the presence of glass particulates.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA has classified this recall as Class I, which meets the rubric criteria for a Critical severity score.
Plain-English summary
Fresenius Kabi USA, LLC is voluntarily recalling 14,016 vials of Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL). The product is a prescription-only intravenous medication manufactured by Fresenius Kabi in Lake Zurich, IL. The recall is being conducted because of the presence of particulate matter, specifically glass particulates, in the vials.
The affected products include Lot 6120420 (NDC 63323-117-61, Product Code 101761) and Lot 6120341 (NDC 63323-117-69, Product Code NP101761). These vials were distributed nationwide in the United States and Puerto Rico. The FDA has classified this recall as Class I, indicating a reasonable probability that use of the product could cause serious adverse health consequences or death.
Healthcare providers and patients should stop using the affected vials immediately. Consumers should contact their healthcare provider or pharmacist for guidance on alternative treatments or further instructions regarding the recalled product.
The recalled product
- Product
- FLUOROURACIL (FLUOROURACIL)
- Brand
- FLUOROURACIL
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Prescription Injection
- Affected units
- 14,016
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot 6120420 NDC 63323-117-61
- Product Code 101761 and Lot 6120341 NDC 63323-117-69
- Product Code NP101761
UPCs (4)
- 0363323117610
- 0363323117511
- 0363323117696
- 0363323117597
Distribution
Related recalls
Same brand · FLUOROURACIL
- ModerateTaro Recalls Fluorouracil Topical Cream Due to Stability Issues
FDA (Drugs) · 2012-12-12
Same manufacturer · Fresenius Kabi USA, LLC
See all →- SevereFresenius Kabi Recalls Tyenne Injection Due to Glass Particles
FDA (Drugs) · 2026-09-02
- CriticalFresenius Kabi Recalls Morphine Syringes Due to Labeling Error
FDA (Drugs) · 2026-08-26
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26